Detection of extended spectrum beta lactamases, AmpC beta lactamases and metallobetalactamases in clinical isolates of ceftazidime resistant Pseudomonas aeruginosa

Brazilian Journal of Microbiology

Volumn 42, Issue 4, 2011, Pages 1284-1288

  Umadevi, Sivaraman ^a   Joseph, Noyal M ^a   Kumari, Kandha ^a   Easow, Joshy M ^a   Kumar, Shailesh ^a   Stephen, Selvaraj ^a   Srirangaraj, Sreenivasan ^a   Raj, Sruthi ^a  

^a MAHATMA GANDHI MEDICAL COLLEGE AND RESEARCH INSTITUTE   (India)

Author keywords

AmpC; Ceftazidime resistance; Extended spectrum lactamases; Metallo lactamases; Pseudomonas aeruginosa

Indexed keywords

PSEUDOMONAS AERUGINOSA;

EID: 84863156129     PISSN: 15178382     EISSN: 16784405     Source Type: Journal    
DOI: 10.1590/S1517-83822011000400006     Document Type: Article

References (21)

1. Aggarwal, R.; Chaudhary, U.; Bala, K. (2008). Detection of extendedspectrum beta-lactamase in Pseudomonas aeruginosa. Indian J Pathol Microbiol. 51, 222-224.
2. Agrawal, G.; Lodhi, R.B.; Kamalakar, U.P.; Khadse, R.K.; Jalgaonkar, S.V. (2008). Study of metallo-beta-lactamase production in clinical isolates of Pseudomonas aeruginosa. Indian J Med Microbiol. 26, 349-351.
3. Arakawa, Y.; Shibata, N.; Shibayama, K.; Kurokawa, H.; Yagi, T.; Fujiwara, H.; Goto, M. (2000). Convenient test for screening metallo-âlactamase-producing Gram-negative bacteria by using thiol compounds. J Clin Microbiol. 38, 40-43.
4. Bhattacharjee, A.; Anupurba, S.; Gaur, A.; Sen, M.R. (2008). Prevalence of inducible AmpC beta-lactamase-producing Pseudomonas aeruginosa in a tertiary care hospital in northern India. Indian J Med Microbiol. 26, 89-90.
5. st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev. 14, 933-51.
6. Chastre, J.; Fagon, J.Y. (2002). Ventilator-associated pneumonia. Am J Respir Crit Care Med. 165, 867-903.
7. Chen, H.Y.; Yuan, M.; Livermore, D.M. (1995). Mechanisms of resistance to beta-lactam antibiotics amongst Pseudomonas aeruginosa isolates collected in the UK in 1993. J Med Microbiol. 43, 300-309.
8. th ed. Approved standards, M2-A9, Wayne, PA.
9. Clinical Laboratory Standards Institute (2007). Performance standards for antimicrobial susceptibility testing. Sixteenth informational supplement. Approved standards, M100 -S16, Wayne, PA.
10. Dong, F.; Xu, X.W.; Song, W.Q.; Lu, P.; Yu, S.J.; Yang, Y.H.; Shen, X.Z. (2008). Characterization of multidrug-resistant and metallo-betalactamase-producing Pseudomonas aeruginosa isolates from a paediatric clinic in China. Chin Med J (Engl). 121, 1611-1616.
11. Govan, J.R.V. (1996). Pseudomonas, Stenotrophomonas, Burkholderia. In: Collee, J.G., Fraser, A.C., Marmion, B.P., Simmons, A.(eds). Mackie & McCartney Practical Medical Microbiology. Churchill Livingstone, New York, USA, p.413-424.
12. Jiang, X.; Zhang, Z.; Li, M.; Zhou, D.; Ruan, F.; Lu, Y. (2006). Detection of extended-spectrum beta-lactamases in clinical isolates of Pseudomonas aeruginosa. Antimicrob Agents Chemother. 50, 2990-2995.
13. Noyal, M.J.; Menezes, G.A.; Harish, B.N.; Sujatha, S.; Parija, S.C. (2009). Simple screening tests for detection of carbapenemases in clinical isolates of nonfermentative Gram-negative bacteria. Indian J Med Res. 129, 707-712.
14. Parveen, M.; Harish, B. N.; Parija, S. C. (2010). AmpC beta lactamases among gram negative clinical isolates from a tertiary hospital, South India. Braz J Microbiol. 41, 596-602.
15. Pasteran, F.; Faccone, D.; Petroni, A.; Rapoport, M.; Galas, M.; Vazquez, M.; Procopio, A. (2005). Novel variant (bla(VIM-11)) of the metallo-{beta}-lactamase bla(VIM) family in a GES-1 extendedspectrum-{beta}-lactamase-producing Pseudomonas aeruginosa clinical isolate in Argentina. Antimicrob Agents Chemother. 49, 474-475.
16. Pellegrino, F.L.; Teixeira, L.M.; Carvalho Md, M.G.; Aranha, N.S., Pinto De, O.M., Mello Sampaio, J.L., D'Avila, F.A., Ferreira, A.L., morim Ed, E.L., Riley, L.W., Moreira, B.M. (2002). Occurrence of a multidrugresistant Pseudomonas aeruginosa clone in different hospitals in Rio de Janeiro, Brazil. J Clin Microbiol. 40, 2420-2424.
17. Picao, R.C.; Poirel, L.; Gales, A.C.; Nordmann, P. (2009). Diversity of beta-lactamases produced by ceftazidime-resistant Pseudomonas aeruginosa isolates causing bloodstream infections in Brazil. Antimicrob Agents Chemother. 53, 3908-3913.
18. Saderi, H.; Karimi, Z.; Owlia, P.; Bahar, M.A.; Rad, S.M.B.A. (2008). Phenotypic Detection of Metallo-beta-lactamase Producing Pseudomonas aeruginosa Strains Isolated from Burned Patients. Iranian Journal of Pathology. 3, 20-24.
19. Singhal, S.; Mathur, T.; Khan, S.; Upadhyay, D. J.; Chugh, S.; Gaind, R.; Rattan, A. (2005). Evaluation of methods for AmpC beta-lactamase in gram negative clinical isolates from tertiary care hospitals. Indian J Med Microbiol. 23, 120-124.
20. Walsh, T.R.; Toleman, M.A.; Poirel, L.; Nordmann, P. (2005). Metallobeta-lactamases: the quiet before the storm? Clin Microbiol Rev. 18, 306-325.
21. Yong, D.; Lee, K.; Yum, J.H.; Shin, H.B.; Rossolini, G.M.; Chong, Y. (2002). Imipenem-EDTA disk method for differentiation of metallo-betalactamase-producing clinical isolates of Pseudomonas spp. and Acinetobacter spp. J Clin Microbiol. 40, 3798-3801.